Category Health & pharma
Structure Therapeutics stock: what’s driving sudden 103% jump in GPCR shares?
Structure Therapeutics stock (NASDAQ: GPCR) rocketed above 103% Monday, trading near $70, after the clinical-stage biotech released promising mid-s...
Dec, 08, 2025
2 min read
by Invezz
Yardeni ends 15-year bullish call on Magnificent 7 as concentration risks climb
Yardeni Research has scrapped its long-running overweight stance on the so-called Magnificent 7, warning that the dominance of America’s largest te...
Dec, 08, 2025
3 min read
by Invezz
Healthcare stocks dubbed ‘the ultimate hedge’ against AI correction
Kepler Cheuvreux head of economics and cross asset strategy, Arnaud Girod, recommends gaining or growing exposure to healthcare stocks if you’re co...
Dec, 05, 2025
2 min read
by Invezz
Wockhardt jump 13% as US FDA accepts NDA for Zaynich antibiotic in key milestone for Indian pharma
Shares of Indian pharmaceutical major Wockhardt rallied more than 13% on Monday after it announced a milestone development in its innovation pipeli...
Dec, 01, 2025
3 min read
by Invezz
Winners vs. losers in a bruised November: can the S&P 500 recover in December?
The US stock market ended November on a softer footing than history would typically suggest, with the S&P 500 down by 0.6% over the month as of Fri...
Nov, 30, 2025
4 min read
by Invezz